BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24047819)

  • 1. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.
    Llorens F; Ansoleaga B; Garcia-Esparcia P; Zafar S; Grau-Rivera O; López-González I; Blanco R; Carmona M; Yagüe J; Nos C; Del Río JA; Gelpí E; Zerr I; Ferrer I
    Prion; 2013; 7(5):383-93. PubMed ID: 24047819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease.
    Gelpi E; Baiardi S; Nos C; Dellavalle S; Aldecoa I; Ruiz-Garcia R; Ispierto L; Escudero D; Casado V; Barranco E; Boltes A; Molina-Porcel L; Bargalló N; Rossi M; Mammana A; Tiple D; Vaianella L; Stoegmann E; Simonitsch-Klupp I; Kasprian G; Klotz S; Höftberger R; Budka H; Kovacs GG; Ferrer I; Capellari S; Sanchez-Valle R; Parchi P
    Acta Neuropathol Commun; 2022 Aug; 10(1):114. PubMed ID: 35978418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    J Biol Chem; 2007 Oct; 282(41):30022-8. PubMed ID: 17709374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease.
    Sikorska B; Knight R; Ironside JW; Liberski PP
    Adv Exp Med Biol; 2012; 724():76-90. PubMed ID: 22411235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan.
    Fukushima R; Shiga Y; Nakamura M; Fujimori J; Kitamoto T; Yoshida Y
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):485-7. PubMed ID: 14966171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
    Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
    Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-occurrence of types 1 and 2 PrP(res) in sporadic Creutzfeldt-Jakob disease MM1.
    Kobayashi A; Mizukoshi K; Iwasaki Y; Miyata H; Yoshida Y; Kitamoto T
    Am J Pathol; 2011 Mar; 178(3):1309-15. PubMed ID: 21356381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's Disease.
    Zafar S; Younas N; Correia S; Shafiq M; Tahir W; Schmitz M; Ferrer I; Andréoletti O; Zerr I
    Mol Neurobiol; 2017 Jan; 54(1):697-709. PubMed ID: 26768426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creutzfeldt-Jakob Disease Subtype-Specific Regional and Temporal Regulation of ADP Ribosylation Factor-1-Dependent Rho/MLC Pathway at Pre-Clinical Stage.
    Zafar S; Schmitz M; Younus N; Tahir W; Shafiq M; Llorens F; Ferrer I; Andéoletti O; Zerr I
    J Mol Neurosci; 2015 Jun; 56(2):329-48. PubMed ID: 25896910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress.
    Tahir W; Zafar S; Llorens F; Arora AS; Thüne K; Schmitz M; Gotzmann N; Kruse N; Mollenhauer B; Torres JM; Andréoletti O; Ferrer I; Zerr I
    Mol Neurobiol; 2018 Jan; 55(1):517-537. PubMed ID: 27975168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
    Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA
    PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional pattern of microgliosis in sporadic Creutzfeldt-Jakob disease in relation to phenotypic variants and disease progression.
    Franceschini A; Strammiello R; Capellari S; Giese A; Parchi P
    Neuropathol Appl Neurobiol; 2018 Oct; 44(6):574-589. PubMed ID: 29345730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases.
    Zhang W; Orrú CD; Foutz A; Ding M; Yuan J; Shah SZA; Zhang J; Kotobelli K; Gerasimenko M; Gilliland T; Chen W; Tang M; Cohen M; Safar J; Xu B; Hong DJ; Cui L; Hughson AG; Schonberger LB; Tatsuoka C; Chen SG; Greenlee JJ; Wang Z; Appleby BS; Caughey B; Zou WQ
    Acta Neuropathol; 2024 Jan; 147(1):17. PubMed ID: 38231266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of I137M and other mutations that modulate incubation periods for two human prion strains.
    Giles K; De Nicola GF; Patel S; Glidden DV; Korth C; Oehler A; DeArmond SJ; Prusiner SB
    J Virol; 2012 Jun; 86(11):6033-41. PubMed ID: 22438549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.